Cytokinetics | CYTK - Vermögenswerte

Aktienkurs
62.19
Täglich Wechseln
0.49 0.79%
Monatlich
-11.28%
Jährlich
33.54%
Q1 Prognose
59.85




Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Amgen USD 90.59B 445M 2025-12
Arca Biopharma USD 488.62M 20.63M 2025-12
Bayer EUR 104.54B 331M 2025-12
Biogen USD 29.44B 232M 2025-12
Brainstorm Cell Therapeutics USD 1.38M 1.19M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Capricor Therapeutics USD 355.95M 229.51M 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Geron USD 570.54M 3.16M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Merck USD 129.55B 12.02B 2025-09
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12